Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)

The Bronx, New York

OncologyPhase II

Compare Sign in to watch

What changed

NIH UM1 · $0.3M · Data Analysis Center for Somatic Mosaicism Across Human Tissues Network

2mo agoGrant renewalMay 13, 2026Source filing (opens the source filing in a new tab)

Momentum

75no change

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase II

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

Grant
R01 · $712k · non-dilutive
May 16, 2025
MASSACHUSETTS GENERAL HOSPITAL · PI RUEDA, BO R. · NCI · award ends Apr 30, 2030 · Defining the genomic and biologic impact of LINE-1 activity in fallopian tube epithelial cells
NIH RePORTER · NIH RePORTER 11331303 (opens the source filing in a new tab)
Trial
PHASE2 registered
Jan 1, 2025
Neuroblastoma, Pheochromocytoma, Paraganglioma · WITHDRAWN · sponsor: Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC) · 18F-mFBG Expression in Neural Crest Tumors and Organs Innervated by the Sympathetic Nervous System
ClinicalTrials.gov · NCT06233903 (opens the source filing in a new tab)
Grant
UM1 · $339k · non-dilutive
May 1, 2023
HARVARD MEDICAL SCHOOL · PI PARK, PETER J · NIDA · award ends Apr 30, 2028 · Data Analysis Center for Somatic Mosaicism Across Human Tissues Network
NIH RePORTER · NIH RePORTER 11380641 (opens the source filing in a new tab)
Grant
UH3 · $712k · non-dilutive
Apr 1, 2023
BOSTON CHILDREN'S HOSPITAL · PI CHOUDHURY, SANGITA · NINDS · award ends Mar 31, 2028 · Detection and Characterization of Somatic Mutations in Human Tissue Utilizing Duplex-Consensus Sequencing
NIH RePORTER · NIH RePORTER 11329074 (opens the source filing in a new tab)
Grant
UH3 · $674k · non-dilutive
Apr 1, 2023
BOSTON CHILDREN'S HOSPITAL · PI WALSH, CHRISTOPHER A. · NINDS · award ends Mar 31, 2028 · Development of an Efficient High Throughput Technique for the Identification of High-Impact Non-Coding Somatic Variants Across Multiple Tissue Types
NIH RePORTER · NIH RePORTER 11348892 (opens the source filing in a new tab)
Grant
UH3 · $699k · non-dilutive
Apr 1, 2023
DANA-FARBER CANCER INST · PI BURNS, KATHLEEN H · NINDS · award ends Mar 31, 2028 · Single Molecule Detection of L1 Insertions and Intermediates
NIH RePORTER · NIH RePORTER 11332505 (opens the source filing in a new tab)
Grant
R01 · $837k · non-dilutive
Sep 15, 2022
BOSTON CHILDREN'S HOSPITAL · PI LEE, ALICE EUNJUNG · NIA · award ends Jun 30, 2027 · Role of transposon dysregulation in Alzheimer and aging brains revealed by single-cell genomic and transcriptomic analysis
NIH RePORTER · NIH RePORTER 11118796 (opens the source filing in a new tab)
Grant
R01 · $453k · non-dilutive
May 5, 2022
HARVARD MEDICAL SCHOOL · PI PARK, PETER J · NCI · award ends Apr 30, 2027 · Mutational signature analysis: methods and applications to the clinic
NIH RePORTER · NIH RePORTER 11305288 (opens the source filing in a new tab)
Grant
R37 · $855k · non-dilutive
Dec 1, 1997
BOSTON CHILDREN'S HOSPITAL · PI WALSH, CHRISTOPHER A. · NINDS · award ends Nov 30, 2028 · Human Epilepsy Genetics - Mosaic Mutations in Focal Epilepsy
NIH RePORTER · NIH RePORTER 11238895 (opens the source filing in a new tab)

How this crosswalk was built

Confidence 75%Edges merged automatically, not yet reviewed by a human

Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator

Links score at or above 0.86 to merge automatically. Anything below that and above the review line goes to a human queue. Resolution is a judgment, and it can be wrong. How resolution works.

Event stream

Every scored event, newest first. This is what momentum is computed from.

NIH UM1 · $0.3M · Data Analysis Center for Somatic Mosaicism Across Human Tissues Network
2mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.7M · Defining the genomic and biologic impact of LINE-1 activity in fallopian tube epithelial cells
2mo agoGrant renewalSource (opens the source filing in a new tab)
NIH UH3 · $0.7M · Development of an Efficient High Throughput Technique for the Identification of High-Impact Non-Coding Somatic Variants Across Multiple Tissue Types
3mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.5M · Mutational signature analysis: methods and applications to the clinic
3mo agoGrant renewalSource (opens the source filing in a new tab)
NIH UH3 · $0.7M · Single Molecule Detection of L1 Insertions and Intermediates
3mo agoGrant renewalSource (opens the source filing in a new tab)
NIH UH3 · $0.7M · Detection and Characterization of Somatic Mutations in Human Tissue Utilizing Duplex-Consensus Sequencing
4mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R37 · $0.9M · Human Epilepsy Genetics - Mosaic Mutations in Focal Epilepsy
6mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.8M · Role of transposon dysregulation in Alzheimer and aging brains revealed by single-cell genomic and transcriptomic analysis
10mo agoGrant renewalSource (opens the source filing in a new tab)
Phase II trial registered: 18F-mFBG Expression in Neural Crest Tumors and Organs Innervated by the Sympathetic Nervous System
Jan 2025Trial registeredSource (opens the source filing in a new tab)

Last disclosed raise

No Form D is on file, so there is no raise to model a runway from. That is why the runway reads “—” rather than a number. It does not mean the company has no money: grants, revenue and notes below the Form D threshold are all invisible here.

Something wrong on this page? The crosswalk is a judgment and we would rather hear it. Report a bad link.

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources

Grant to raise

R01 · $712k · non-dilutive

PHASE2 registered

UM1 · $339k · non-dilutive

UH3 · $712k · non-dilutive

UH3 · $674k · non-dilutive

UH3 · $699k · non-dilutive

R01 · $837k · non-dilutive

R01 · $453k · non-dilutive

R37 · $855k · non-dilutive